Inari Medical Inc NARI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
93.75UNCH (UNCH)
Volume
7,788
Close
93.75quote price arrow down-2.35 (-2.45%)
Volume
541,682
52 week range
39.55 - 120.00

...

Loading . . .

KEY STATS

  • Open97.63
  • Day High97.99
  • Day Low88.26
  • Prev Close96.10
  • 52 Week High120.00
  • 52 Week High Date02/19/21
  • 52 Week Low39.55
  • 52 Week Low Date05/22/20
  • Market Cap4.567B
  • Shares Out48.71M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.06
  • P/E (TTM)1,624.78
  • Fwd P/E (NTM)3,125.00
  • EBITDA (MRQ)13.82M
  • ROE (MRQ)-
  • Revenue (MRQ)110.95M
  • Gross Margin (MRQ)89.58%
  • Net Margin (MRQ)6.45%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Inari Medical Inc News

There is no recent news for this security.

Latest NARI News From Our Partners

QUOTE FINDER

Profile

MORE
Inari Medical, Inc. is a commercial-stage medical device company. The Company is focused on developing products to treat venous diseases. The Company’s product offering consists of two minimally-invasive, catheter-based mechanical thrombectomy devices. The Company built two products for the treatment of venous thromboembolism (VTE deep vein thrombosis) and pulmonary embolism (PE). The Company provides two products ClotTriever and FlowTriever. ClotTriever product is Food and...
Donald Milder
Non-Executive Chairman
William Hoffman
President
Andrew Hykes
Chief Operating Officer
Mitchell Hill
Chief Financial Officer
Address
9 Parker, Suite 100, Suite 100
Irvine, CA
92618
United States